Brimonidine tartrate

Known as: Tartrate, Brimonidine, 6-Quinoxalinamine, 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-,(2R,3R)-2,3-dihydroxybutanedioate(1:1), 5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline D-tartrate 
The tartrate salt form of brimonidine, an imidazole derivative and a selective alpha-2 adrenergic receptor agonist. Upon ocular administration… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1993-2017
0102019932017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
PURPOSE To compare the alpha2-adrenergic agonist brimonidine tartrate 0.2% to the beta-adrenergic antagonist timolol maleate 0.5… (More)
Is this relevant?
2006
2006
OBJECTIVE To evaluate the intraocular pressure (IOP)-lowering efficacy and safety of a fixed combination of 0.2% brimonidine… (More)
Is this relevant?
2004
2004
PURPOSE To evaluate the effect of brimonidine tartrate 0.2% ophthalmic solution on pupil size under scotopic and photopic… (More)
Is this relevant?
2002
2002
OBJECTIVES Brimonidine tartrate ophth, an alpha(2)-adrenergic agonist, is widely used as an antiglaucoma agent for lowering… (More)
Is this relevant?
2001
2001
OBJECTIVE To determine the vitreous concentration of brimonidine after topical administration of Alphagan. DESIGN Prospective… (More)
Is this relevant?
2001
2001
PURPOSE To evaluate the effect of brimonidine tartrate ophthalmic solution 0.2% (Alphagan) on pupil size in normal eyes. Three… (More)
Is this relevant?
2000
2000
PURPOSE To study the effects of topical brimonidine tartrate 0.2%, an alpha(2)-agonist ocular hypotensive drug, on retinal… (More)
Is this relevant?
1998
1998
OBJECTIVE To study the effect of a selective alpha 2-adrenoreceptor agonist, brimonidine tartrate, on ocular hemodynamics… (More)
Is this relevant?
1997
1997
BACKGROUND Brimonidine tartrate is a relatively selective alpha2-agonist that effectively reduces mean intraocular pressure (IOP… (More)
Is this relevant?
Highly Cited
1995
Highly Cited
1995
OBJECTIVE To evaluate the mechanism by which brimonidine, a selective alpha 2-adrenergic agonist, lowers intraocular pressure… (More)
Is this relevant?